Velox Details
Sensitivum relativum: 96.97%（95%CI：83.35%～99.99%）
Relativum Specificationis: 1000.00%（95%CI：97.29%～100.00%）
Cura: 99.50%（95%CI：96.94%～99.99%）
Packaging & Delivery
| Packaging detail: Latin export sarcina Partus detail: in 7-10 fes post recepcionem solucionis |
Specifications
Lepu Celeri test kit AMRDT120 for sale
Celeri test ad qualitatem deprehensio neutralisandi
elementorum ad sars-CoV-II vel vaccina in toto sanguine, seri vel plasma.
Sarcina Specification: 40 T/ornamentum, 20 T/ornamentum, 10 T/ornamentum, 1 T/ornamentum.
Sensitivum relativum: 96.97%（95%CI：83.35%～99.99%）
Relativum Specificationis: 1000.00%（95%CI：97.29%～100.00%）
Cura: 99.50%（95%CI：96.94%～99.99%）
Claua mantica, cum test casssttes et desiccantes* 20
Tende quiddam* 20 phialas;
Disposable droppers*20;
Lancea *20
Lodine swab*20
Instructionem ad usum * 1
Lepu Celeri test ornamentum AMRDT120 intentum usum
Sars-CoV-2 Anticorpus celeri test (COVID-19 Ab) celeri chromatographico immunoassay est pro qualitate detectionis elementorum ad SARS-CoV-2 corrumpendi in toto sanguine, serum, vel plasmate.
Lepu Celeri test ornamentum AMRDT120 PRINCIPIUM
Sars-CoV-2 Anticorpus celeri test (COVID-19 Ab) deprehensio elementorum ad SARS-CoV-2 vel vaccina est deprehendendi.Superficies cellae receptae angiotensin enzyme-2 (ACE2) in regione test recta obductis et recombinantis dominii receptatoris ligandi (RBD) cum particulis indicatis coniunguntur.
In probatione, si elementa in specimine SARS-CoV-2 neutralia sint, agere cum interdum RBD-particula conjugata et non agere cum dapibus ACE2 praelibatis.Mixtura ergo migrat sursum in membranam chromatographicam actionem capillarem et ab antigene praelibata non capta.Sars-CoV-2 Anticorpus celeri test (COVID-19 Ab) impediens particulas RBD-coactas continet.Dapibus ACE2 in regione test lineae obductis sunt.
